Japan launches commercial use of stem cell heart therapy
A Japanese hospital performed the first transplant of cardiac cell sheets derived from stem cells using a commercially approved treatment.
Written by EGazette’s AI. The facts are drawn from cited sources; the analysis is the AI’s own.

Japan has launched the commercial use of a new stem cell-based heart treatment, after a Japanese hospital performed what has been described as the world's first surgery to transplant sheets of cardiac muscle cells derived from stem cells.
According to one of the surgeons involved in the procedure, this treatment has received conditional government approval allowing it to be offered for commercial use — a world first in this medical field.
A promising technology
The technique involves transplanting thin sheets made of cardiac muscle cells derived from stem cells, with the aim of helping repair or regenerate damaged heart tissue in patients suffering from heart disease.
Full details regarding the number of patients targeted by this treatment or the associated costs have not yet been disclosed, as the medical community awaits further data on the initial outcomes of the procedure that was performed.
This step comes in the context of ongoing Japanese efforts to develop advanced stem cell-based therapies, with Japan considered one of the world's leading countries in regenerative medicine research for many years.
Specialists believe that the success of this type of therapy could open the door to similar applications for treating other conditions that require the repair or regeneration of damaged tissue, though the matter still requires further long-term studies and follow-up to evaluate its efficacy and safety on a wider scale.
Japanese authorities have not yet set a timeline for expanding the use of this treatment to include other hospitals within the country or abroad.
Sources
- اليابان تبدأ استخدام علاج للقلب بالخلايا الجذعية تجاريا — Sky News Arabia — Technology
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Comments
Loading comments…
Related articles

Split Views Emerge on Whether NFL Players Would Take a Living CTE Test
With research on chronic traumatic encephalopathy advancing, ESPN surveyed NFL players on whether they would want to know if they had the disease while still alive.

NFL Players Describe a Range of Emotions in Coping With CTE Concerns
In interviews with more than 30 NFL players, ESPN found reactions to the risk of chronic traumatic encephalopathy ranging from fear to acceptance.
Lady A singer Charles Kelley reveals blood cancer diagnosis
The Grammy-winning country music star says he currently feels "great" and remains hopeful following his diagnosis.
Pakistani Medical University Holds Workshop on Rabies Prevention and Treatment
Liaquat University of Medical and Health Sciences organized the session for its department of infectious diseases on the instructions of its vice chancellor.
The 'Empty Chair' Initiative Helping People Talk About Mental Health
After losing his best friend to suicide, Dean Perryman started reserving an empty chair in a pub for anyone who needs someone to talk to.

Measles exposures spread to trains and sports venues as outbreaks grow
With active outbreaks in Pennsylvania, Ohio and New York, health officials are urging travellers to check their vaccination status before using shared transport.